Life Science & Biotech

Roche Diagnostics to get indirect boon from new test

August 22, 2011
J.K. Wall
New drug for metastatic melanoma packaged with genetic test should help Roche sell more of its cobas 4800 laboratory testing systems.
More

Inventor on quest to bring medical device to marketRestricted Content

August 13, 2011
Chris O'Malley
Licensed practical nurse Nic Davis invented a device to kill and prevent the introduction of microorganisms that collect at catheter ports.
More

Glick support boosts IU eye researchRestricted Content

August 13, 2011
 IBJ Staff
A $10 million research endowment at the Eugene and Marilyn Glick Eye Institute has attracted seven new researchers to the Indiana University School of Medicine’s Ophthalmology Department.
More

Health care VC slows in 2011

August 8, 2011
J.K. Wall
Four Hoosier companies attracted more than $10.5 million, down from 10 companies that attracted $18.5 million during the first half of 2010.
More

Zimmer playing hardball with plaintiffs' lawyers

August 8, 2011
Bloomberg News
The Warsaw-based company has sued seven law firms this year and sent warning letters to at least three more, saying their ads and Internet postings distorted the safety record of its $1.8 billion-a-year knee business.
More

Medical implant maker plans move from northern Indiana

August 4, 2011
Associated Press
Rochester Medical Implants plans to move operations from Rochester to Noblesville in October. The company has 28 employees.
More

Packaging manufacturer plans to expand, add 80 jobs

August 2, 2011
Indianapolis-based DGP Intelsius LLC, a manufacturer and distributor of temperature-controlled packaging, announced on Tuesday morning that it plans to add 80 jobs by 2014 as part of an $870,000 expansion.
More

More life sciences firms opt to launch products in EuropeRestricted Content

July 30, 2011
Maria LaMagna
The U.S. Food and Drug Administration's growing reputation for unpredictability is spurring some Indianapolis companies to join counterparts elsewhere and introduce products in Europe. The upshot is that some Americans may never benefit from innovations occurring in their backyards.
More

Indiana life sciences leaders look toward the futureRestricted Content

July 30, 2011
Chris O'Malley
Former Eli Lilly and Co. vice president Richard Dimarchi, BioCrossroads President David Johnson, angel investor Oscar Moralez and Purdue University Senior Vice President Alan Rebar discuss issues ranging from the depth of the life sciences industry in Indiana to venture capital and Purdue's Discovery Park.
More

Eli Lilly's Elanco unit blossoming at just the right timeRestricted Content

July 30, 2011
Greg Andrews
An investment firm projects that the Elanco animal-health business will generate sales of nearly $2 billion by 2012 and surpass $3 billion by 2018.
More

Angel investment firm adds 3rd chapter for life sciences

July 27, 2011
Chris O'Malley
Moralez_watch_videoStepStone Business Partners has added a chapter in biotech hotbed Warsaw as part of what it hopes will eventually become a statewide network.
More

Dow AgroSciences reports record sales, higher earnings

July 27, 2011
Second-quarter revenue for the Indianapolis-based company increased 18 percent, to $1.5 billion. The company attributed the gain to higher prices and stronger demand for its products.
More

Tech district could boost Indianapolis' convention businessRestricted Content

July 23, 2011
Scott Olson
The Indianapolis Convention & Visitors Association plans to attract more life sciences conferences.
More

Pfizer won’t break up animal unit for potential Lilly bid

July 21, 2011
Bloomberg News
Pfizer Inc., the world’s biggest drugmaker, said it isn’t interested in breaking up its animal health unit after Indianapolis-based Eli Lilly and Co. expressed interest in buying some of its products.
More

Lilly loses bid to end revived Zyprexa U.K. patent case

July 5, 2011
Bloomberg News
The High Court in London on Tuesday denied Lilly’s request for a judgment without trial against Neopharma Ltd., the closely held company that has European marketing rights for the generic version of the drug known chemically as olanzapine.
More

Timing good for 2-in-1 biotech drugs

July 5, 2011
J.K. Wall
Eli Lilly and Co.’s foray into combination drugs is well-timed because the company could take advantage of some the world’s most successful biotech medicines, which are about to see their patents expire.
More

Lilly plans more investment in two-in-one drugs

June 28, 2011
J.K. Wall
Indianapolis-based drugmaker Eli Lilly on Tuesday will announce a multimillion-dollar investment to develop drugs that act like two medicines in one. Lilly plans to add more scientists to back the effort.
More

Lilly CEO: Immigration, tax laws slow innovation

June 23, 2011
Bloomberg News
The U.S. government needs to open its borders to attract and retain talented scientists for drugmakers to employ, Eli Lilly & Co. CEO John Lechleiter plans to tell a technology conference Thursday.
More

2010 was great for Indiana's 100 largest companiesRestricted Content

June 18, 2011
Norm Heikens
Despite enjoying rising revenues and profits, companies haven't followed with big increases in job numbers.
More

City leaders look to 16th Street as future tech hub

June 16, 2011
Francesca Jarosz
Officials on Thursday shared details of a long-term plan to redevelop an industrial stretch northwest of downtown with the goal of attracting hundreds of residents and dozens of high-tech companies to the area.
More

Q&A

June 13, 2011
J.K. Wall
Vi Shukla is a scientific leader at Indianapolis-based Dow AgroSciences LLC, focused on its Exzact Precision Technology tools for genetic engineering of plants and crops. Dow Agro used the technology in its own crop seed products, and has also been licensing for use in tomatos and trees.
More

Anson Group CEO thrives on helping clients work with FDARestricted Content

June 11, 2011
Ann Finch
Colleen Hittle became CEO and sole owner of the Indianapolis-based pharmaceutical and medical device consulting firm in April.
More

City to roll out plan for 16th Street tech corridor

June 10, 2011
Francesca Jarosz
The city of Indianapolis plans to announce a major initiative to turn a stretch of 16th Street northwest of downtown into a hub for biotechnology and other high-tech companies.
More

Roche wins as high court limits university patent rights

June 6, 2011
Bloomberg News
Monday's Supreme Court decision is a victory for companies that collaborate with universities in research. Indianapolis-based Eli Lilly and Co. was among the companies that supported Roche.
More

Life sciences logistics firm opens new tissue storage facility

May 27, 2011
J.K. Wall
BioStorage Technologies' $4.6 million facility, located near the Indianapolis International Airport, will be used to prepare, store and transport tissue and blood samples.
More
Page  << 1 2 3 4 5 6 7 8 9 10 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT